SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4lq1'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A8U_A_BEZA295_0 (CHLOROPEROXIDASE T)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 10	GLY A 398 PHE A 397 LEU A 402 PHE A 318 TRP A 393	None	0.86A	1a8uA-4lq1A: undetectable	1a8uA-4lq1A: 18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A8U_B_BEZB294_0 (CHLOROPEROXIDASE T)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 10	GLY A 398 PHE A 397 LEU A 402 PHE A 318 TRP A 393	None	0.90A	1a8uB-4lq1A: undetectable	1a8uB-4lq1A: 18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DED_B_QPSB1501_1 (CYCLODEXTRIN GLUCANOTRANSFERASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	6 / 12	TYR A 300 ARG A 403 ASP A 405 ALA A 406 HIS A 525 ASP A 526	None	0.79A	1dedB-4lq1A: 24.2	1dedB-4lq1A: 22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZ6_A_CAMA502_0 (CYTOCHROME P450-CAM)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 5	TYR A 300 LEU A 287 VAL A 529 ASP A 526	None	1.49A	1dz6A-4lq1A: undetectable	1dz6A-4lq1A: 21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ESW_A_ACRA651_1 (AMYLOMALTASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	6 / 12	TYR A 300 GLN A 301 GLU A 458 HIS A 525 ASP A 526 TRP A 298	None	1.15A	1eswA-4lq1A: 15.8	1eswA-4lq1A: 22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GXS_C_BEZC602_0 (P-(S)-HYDROXYMANDELO NITRILE LYASE CHAIN A P-(S)-HYDROXYMANDELO NITRILE LYASE CHAIN B)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 9	PRO A 338 ASP A 405 HIS A 340 MET A 410 ALA A 406	None	1.14A	1gxsC-4lq1A: 0.9 1gxsD-4lq1A: 0.7	1gxsC-4lq1A: 18.45 1gxsD-4lq1A: 14.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HVY_C_D16C416_1 (THYMIDYLATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 11	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.39A	1hvyC-4lq1A: undetectable	1hvyC-4lq1A: 17.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I00_A_D16A315_1 (THYMIDYLATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 9	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.33A	1i00A-4lq1A: undetectable	1i00A-4lq1A: 17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I00_B_D16B409_1 (THYMIDYLATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 9	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.38A	1i00B-4lq1A: undetectable	1i00B-4lq1A: 17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KXH_A_ACRA598_1 (ALPHA-AMYLASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	GLN A 301 HIS A 340 ALA A 406 GLU A 458 ASP A 526	None	1.05A	1kxhA-4lq1A: 22.0	1kxhA-4lq1A: 21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OLT_A_SAMA502_0 (OXYGEN-INDEPENDENT COPROPORPHYRINOGEN III OXIDASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 9	GLY A 161 GLU A 191 PHE A 140 LEU A 177 ILE A 179	None	1.45A	1oltA-4lq1A: undetectable	1oltA-4lq1A: 22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RI4_A_SAMA299_0 (MRNA CAPPING ENZYME)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	GLY A 668 GLY A 706 ILE A 702 ALA A 703 ASP A 700	None	1.17A	1ri4A-4lq1A: undetectable	1ri4A-4lq1A: 19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_C_CHDC3525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.48A	1v54A-4lq1A: undetectable 1v54C-4lq1A: undetectable	1v54A-4lq1A: 21.78 1v54C-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_P_CHDP4525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	1v54N-4lq1A: undetectable 1v54P-4lq1A: undetectable	1v54N-4lq1A: 21.78 1v54P-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_C_CHDC3525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.45A	1v55A-4lq1A: 2.0 1v55C-4lq1A: undetectable	1v55A-4lq1A: 21.78 1v55C-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	2dyrA-4lq1A: undetectable 2dyrC-4lq1A: undetectable	2dyrA-4lq1A: 21.78 2dyrC-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.46A	2dyrN-4lq1A: 2.0 2dyrP-4lq1A: undetectable	2dyrN-4lq1A: 21.78 2dyrP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.48A	2dysA-4lq1A: undetectable 2dysC-4lq1A: undetectable	2dysA-4lq1A: 21.78 2dysC-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_P_CHDP304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.45A	2dysN-4lq1A: undetectable 2dysP-4lq1A: undetectable	2dysN-4lq1A: 21.78 2dysP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.44A	2eijA-4lq1A: undetectable 2eijC-4lq1A: undetectable	2eijA-4lq1A: 21.78 2eijC-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.46A	2eijN-4lq1A: 2.1 2eijP-4lq1A: undetectable	2eijN-4lq1A: 21.78 2eijP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	2eikA-4lq1A: 2.0 2eikC-4lq1A: undetectable	2eikA-4lq1A: 21.78 2eikC-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	2eikN-4lq1A: 2.1 2eikP-4lq1A: undetectable	2eikN-4lq1A: 21.78 2eikP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	2eilN-4lq1A: undetectable 2eilP-4lq1A: undetectable	2eilN-4lq1A: 21.78 2eilP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.43A	2eimA-4lq1A: undetectable 2eimC-4lq1A: undetectable	2eimA-4lq1A: 21.78 2eimC-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.45A	2einA-4lq1A: undetectable 2einC-4lq1A: undetectable	2einA-4lq1A: 21.78 2einC-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.46A	2einN-4lq1A: undetectable 2einP-4lq1A: undetectable	2einN-4lq1A: 21.78 2einP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HMY_B_SAMB328_0 (PROTEIN (CYTOSINE-SPECIFIC METHYLTRANSFERASE HHAI))	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	PHE A 318 GLY A 251 ASP A 323 ILE A 322 PRO A 308	None	1.05A	2hmyB-4lq1A: undetectable	2hmyB-4lq1A: 19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OWC_A_ACRA600_1 (4-ALPHA-GLUCANOTRANS FERASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	6 / 11	TYR A 300 GLN A 301 ASP A 405 HIS A 525 ASP A 526 TRP A 298	None	1.16A	2owcA-4lq1A: 15.2	2owcA-4lq1A: 22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OWW_A_ACRA600_1 (4-ALPHA-GLUCANOTRANS FERASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	6 / 11	TYR A 300 GLN A 301 ASP A 405 HIS A 525 ASP A 526 TRP A 298	None	1.15A	2owwA-4lq1A: 15.2	2owwA-4lq1A: 22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QMZ_B_LDPB502_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 5	PHE A 560 PHE A 641 TRP A 628 GLY A 625	None	1.35A	2qmzA-4lq1A: undetectable 2qmzB-4lq1A: undetectable	2qmzA-4lq1A: 18.49 2qmzB-4lq1A: 18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2TSR_C_D16C509_1 (THYMIDYLATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 10	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.36A	2tsrC-4lq1A: undetectable	2tsrC-4lq1A: 17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2TSR_D_D16D609_1 (THYMIDYLATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 9	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.41A	2tsrD-4lq1A: undetectable	2tsrD-4lq1A: 17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VL2_B_BEZB1162_0 (PEROXIREDOXIN-5)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	PRO A 338 GLY A 339 LEU A 475 PHE A 477	None	0.96A	2vl2B-4lq1A: undetectable	2vl2B-4lq1A: 14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_A_CHDA1517_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.44A	2y69A-4lq1A: 2.0 2y69C-4lq1A: undetectable	2y69A-4lq1A: 21.78 2y69C-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.48A	2zxwA-4lq1A: undetectable 2zxwC-4lq1A: undetectable	2zxwA-4lq1A: 21.78 2zxwC-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.48A	2zxwN-4lq1A: undetectable 2zxwP-4lq1A: undetectable	2zxwN-4lq1A: 21.78 2zxwP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.48A	3abkA-4lq1A: undetectable 3abkC-4lq1A: undetectable	3abkA-4lq1A: 21.78 3abkC-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	3abkN-4lq1A: undetectable 3abkP-4lq1A: undetectable	3abkN-4lq1A: 21.78 3abkP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.48A	3abmN-4lq1A: undetectable 3abmP-4lq1A: undetectable	3abmN-4lq1A: 21.78 3abmP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.49A	3ag1N-4lq1A: undetectable 3ag1P-4lq1A: undetectable	3ag1N-4lq1A: 21.78 3ag1P-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.46A	3ag2A-4lq1A: undetectable 3ag2C-4lq1A: undetectable	3ag2A-4lq1A: 21.78 3ag2C-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.46A	3ag2N-4lq1A: undetectable 3ag2P-4lq1A: undetectable	3ag2N-4lq1A: 21.78 3ag2P-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	3ag3A-4lq1A: undetectable 3ag3C-4lq1A: undetectable	3ag3A-4lq1A: 21.78 3ag3C-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.48A	3ag3N-4lq1A: undetectable 3ag3P-4lq1A: undetectable	3ag3N-4lq1A: 21.78 3ag3P-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.46A	3ag4A-4lq1A: undetectable 3ag4C-4lq1A: undetectable	3ag4A-4lq1A: 21.78 3ag4C-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.44A	3ag4N-4lq1A: undetectable 3ag4P-4lq1A: undetectable	3ag4N-4lq1A: 21.78 3ag4P-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_A_ACRA5044_1 (GLUCOSYLTRANSFERASE- SI)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	ARG A 403 ASP A 405 ALA A 406 HIS A 525 ASP A 526	None	0.86A	3aicA-4lq1A: 2.5	3aicA-4lq1A: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_B_ACRB5044_1 (GLUCOSYLTRANSFERASE- SI)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	ARG A 403 ASP A 405 ALA A 406 HIS A 525 ASP A 526	None	0.88A	3aicB-4lq1A: 4.7	3aicB-4lq1A: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_C_ACRC5044_1 (GLUCOSYLTRANSFERASE- SI)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	6 / 12	ARG A 403 ASP A 405 ALA A 406 HIS A 525 ASP A 526 TYR A 300	None	0.90A	3aicC-4lq1A: 5.7	3aicC-4lq1A: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_D_ACRD5044_1 (GLUCOSYLTRANSFERASE- SI)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	ARG A 403 ASP A 405 ALA A 406 HIS A 525 ASP A 526	None	0.90A	3aicD-4lq1A: 5.3	3aicD-4lq1A: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_E_ACRE5044_1 (GLUCOSYLTRANSFERASE- SI)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	ARG A 403 ASP A 405 ALA A 406 HIS A 525 ASP A 526	None	0.86A	3aicE-4lq1A: 5.6	3aicE-4lq1A: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_F_ACRF5044_1 (GLUCOSYLTRANSFERASE- SI)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	ARG A 403 ASP A 405 ALA A 406 HIS A 525 ASP A 526	None	0.86A	3aicF-4lq1A: 4.1	3aicF-4lq1A: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_G_ACRG5044_1 (GLUCOSYLTRANSFERASE- SI)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	ARG A 403 ASP A 405 ALA A 406 HIS A 525 ASP A 526	None	0.87A	3aicG-4lq1A: 5.6	3aicG-4lq1A: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_H_ACRH5044_1 (GLUCOSYLTRANSFERASE- SI)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	ARG A 403 ASP A 405 ALA A 406 HIS A 525 ASP A 526	None	0.87A	3aicH-4lq1A: 4.6	3aicH-4lq1A: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.46A	3asnA-4lq1A: undetectable 3asnC-4lq1A: undetectable	3asnA-4lq1A: 21.78 3asnC-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JAY_A_SAMA1102_1 (STRUCTURAL PROTEIN VP3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	3 / 3	ARG A 315 ASP A 323 ASP A 316	None	0.76A	3jayA-4lq1A: undetectable	3jayA-4lq1A: 18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JB2_A_SAMA1102_1 (STRUCTURAL PROTEIN VP3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	3 / 3	ARG A 315 ASP A 323 ASP A 316	None	0.86A	3jb2A-4lq1A: undetectable	3jb2A-4lq1A: 18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JB3_A_SAMA1102_1 (STRUCTURAL PROTEIN VP3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	3 / 3	ARG A 315 ASP A 323 ASP A 316	None	0.91A	3jb3A-4lq1A: undetectable	3jb3A-4lq1A: 18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P2K_B_SAMB6735_0 (16S RRNA METHYLASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	PRO A 338 ALA A 390 LEU A 286 THR A 455 LEU A 402	None	1.14A	3p2kB-4lq1A: undetectable	3p2kB-4lq1A: 17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PYY_A_STIA3_2 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	TYR A 375 VAL A 404 ILE A 411 ARG A 444	None	0.92A	3pyyA-4lq1A: undetectable	3pyyA-4lq1A: 20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TYE_B_YTZB902_1 (DIHYDROPTEROATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	3 / 3	PHE A 346 LYS A 202 SER A 203	None	1.33A	3tyeB-4lq1A: 5.0	3tyeB-4lq1A: 18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AC9_C_DXCC1480_0 (MJ0495-LIKE PROTEIN)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 4	LYS A 563 GLU A 285 ILE A 245 SER A 244	None	1.46A	4ac9C-4lq1A: 2.7	4ac9C-4lq1A: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_C_DXCC1480_0 (TRANSLATION ELONGATION FACTOR SELB)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 4	LYS A 563 GLU A 285 ILE A 245 SER A 244	None	1.41A	4acaC-4lq1A: 2.8	4acaC-4lq1A: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACB_C_DXCC1480_0 (TRANSLATION ELONGATION FACTOR SELB)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 4	LYS A 563 GLU A 285 ILE A 245 SER A 244	None	1.42A	4acbC-4lq1A: 2.8	4acbC-4lq1A: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AE1_B_NCAB1536_0 (DIPHTHERIA TOXIN)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 5	HIS A 128 GLY A 126 TYR A 122 TYR A 206	None	1.08A	4ae1B-4lq1A: 3.2	4ae1B-4lq1A: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DO3_B_0LAB602_1 (FATTY-ACID AMIDE HYDROLASE 1)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	LEU A 119 LEU A 391 ILE A 394 TRP A 336	None	0.87A	4do3B-4lq1A: undetectable	4do3B-4lq1A: 21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EB4_C_D16C402_1 (THYMIDYLATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 9	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.38A	4eb4C-4lq1A: undetectable	4eb4C-4lq1A: 17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EB4_D_D16D402_1 (THYMIDYLATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 10	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.36A	4eb4D-4lq1A: undetectable	4eb4D-4lq1A: 17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O4D_A_ACTA406_0 (INOSITOL HEXAKISPHOSPHATE KINASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	THR A 303 PHE A 294 SER A 297 HIS A 292	None	1.39A	4o4dA-4lq1A: undetectable	4o4dA-4lq1A: 16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R82_A_ACTA205_0 (OXIDOREDUCTASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 5	SER A 172 GLY A 173 ARG A 169 GLU A 176	None	1.29A	4r82A-4lq1A: undetectable 4r82B-4lq1A: undetectable	4r82A-4lq1A: 16.33 4r82B-4lq1A: 16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WS0_A_URFA301_1 (URACIL-DNA GLYCOSYLASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	GLY A 126 TYR A 392 PHE A 208 HIS A 128	None	1.14A	4ws0A-4lq1A: undetectable	4ws0A-4lq1A: 15.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.48A	5b1aN-4lq1A: undetectable 5b1aP-4lq1A: undetectable	5b1aN-4lq1A: 21.78 5b1aP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	5b1bN-4lq1A: undetectable 5b1bP-4lq1A: undetectable	5b1bN-4lq1A: 21.78 5b1bP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	5b3sN-4lq1A: undetectable 5b3sP-4lq1A: undetectable	5b3sN-4lq1A: 21.78 5b3sP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H3A_A_D16A401_1 (ORF70)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 7	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.35A	5h3aA-4lq1A: undetectable	5h3aA-4lq1A: 20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	5iy5A-4lq1A: undetectable 5iy5C-4lq1A: undetectable	5iy5A-4lq1A: 21.78 5iy5C-4lq1A: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N0S_B_SAMB501_1 (PEPTIDE N-METHYLTRANSFERASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 4	GLY A 197 ALA A 195 MET A 192 THR A 354	None	1.38A	5n0sB-4lq1A: undetectable	5n0sB-4lq1A: 19.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1B_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 6	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.47A	5x1bN-4lq1A: undetectable 5x1bP-4lq1A: undetectable	5x1bN-4lq1A: 21.78 5x1bP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X5Q_C_D16C402_1 (THYMIDYLATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 7	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.34A	5x5qC-4lq1A: undetectable	5x5qC-4lq1A: 17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X66_D_MTXD402_1 (THYMIDYLATE SYNTHASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 10	PHE A 560 ILE A 511 ASP A 622 GLY A 625 PHE A 626	None	1.33A	5x66D-4lq1A: undetectable	5x66D-4lq1A: 17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	ASP A 491 THR A 489 TYR A 492 TRP A 628	None	1.46A	5zcqN-4lq1A: undetectable 5zcqP-4lq1A: undetectable	5zcqN-4lq1A: 21.78 5zcqP-4lq1A: 18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_B_AQ4B602_0 (CYTOCHROME P450 1A1)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	ILE A 289 ASN A 389 LEU A 305 ASN A 290 ILE A 322	None	1.29A	6dwnB-4lq1A: undetectable	6dwnB-4lq1A: 8.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FZB_B_SRYB301_1 (STREPTOMYCIN 3''-ADENYLYLTRANSFER ASE)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	5 / 12	ASP A 345 ASP A 295 ASP A 335 ILE A 289 THR A 309	None	1.44A	6fzbB-4lq1A: undetectable	6fzbB-4lq1A: 8.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_F_AM2F301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	4lq1	1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB (Escherichia coli)	4 / 7	HIS A 487 HIS A 530 GLU A 527 GLU A 247	None	1.31A	6mn4F-4lq1A: undetectable	6mn4F-4lq1A: 17.46

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1A8U_A_BEZA295_0","CHLOROPEROXIDASE T","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"GLY A 398;PHE A 397;LEU A 402;PHE A 318;TRP A 393","None","0.86A","1a8uA-4lq1A:undetectable","1a8uA-4lq1A:18.03"],["1A8U_B_BEZB294_0","CHLOROPEROXIDASE T","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"GLY A 398;PHE A 397;LEU A 402;PHE A 318;TRP A 393","None","0.90A","1a8uB-4lq1A:undetectable","1a8uB-4lq1A:18.03"],["1DED_B_QPSB1501_1","CYCLODEXTRIN GLUCANOTRANSFERASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",6,"TYR A 300;ARG A 403;ASP A 405;ALA A 406;HIS A 525;ASP A 526","None","0.79A","1dedB-4lq1A:24.2","1dedB-4lq1A:22.36"],["1DZ6_A_CAMA502_0","CYTOCHROME P450-CAM","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"TYR A 300;LEU A 287;VAL A 529;ASP A 526","None","1.49A","1dz6A-4lq1A:undetectable","1dz6A-4lq1A:21.85"],["1ESW_A_ACRA651_1","AMYLOMALTASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",6,"TYR A 300;GLN A 301;GLU A 458;HIS A 525;ASP A 526;TRP A 298","None","1.15A","1eswA-4lq1A:15.8","1eswA-4lq1A:22.24"],["1GXS_C_BEZC602_0","P-(S)-HYDROXYMANDELONITRILE LYASE CHAIN A;P-(S)-HYDROXYMANDELONITRILE LYASE CHAIN B","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PRO A 338;ASP A 405;HIS A 340;MET A 410;ALA A 406","None","1.14A","1gxsC-4lq1A:0.9;1gxsD-4lq1A:0.7","1gxsC-4lq1A:18.45;1gxsD-4lq1A:14.26"],["1HVY_C_D16C416_1","THYMIDYLATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.39A","1hvyC-4lq1A:undetectable","1hvyC-4lq1A:17.45"],["1I00_A_D16A315_1","THYMIDYLATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.33A","1i00A-4lq1A:undetectable","1i00A-4lq1A:17.55"],["1I00_B_D16B409_1","THYMIDYLATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.38A","1i00B-4lq1A:undetectable","1i00B-4lq1A:17.55"],["1KXH_A_ACRA598_1","ALPHA-AMYLASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"GLN A 301;HIS A 340;ALA A 406;GLU A 458;ASP A 526","None","1.05A","1kxhA-4lq1A:22.0","1kxhA-4lq1A:21.69"],["1OLT_A_SAMA502_0","OXYGEN-INDEPENDENT COPROPORPHYRINOGEN III OXIDASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"GLY A 161;GLU A 191;PHE A 140;LEU A 177;ILE A 179","None","1.45A","1oltA-4lq1A:undetectable","1oltA-4lq1A:22.42"],["1RI4_A_SAMA299_0","MRNA CAPPING ENZYME","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"GLY A 668;GLY A 706;ILE A 702;ALA A 703;ASP A 700","None","1.17A","1ri4A-4lq1A:undetectable","1ri4A-4lq1A:19.48"],["1V54_C_CHDC3525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.48A","1v54A-4lq1A:undetectable;1v54C-4lq1A:undetectable","1v54A-4lq1A:21.78;1v54C-4lq1A:18.69"],["1V54_P_CHDP4525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","1v54N-4lq1A:undetectable;1v54P-4lq1A:undetectable","1v54N-4lq1A:21.78;1v54P-4lq1A:18.69"],["1V55_C_CHDC3525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.45A","1v55A-4lq1A:2.0;1v55C-4lq1A:undetectable","1v55A-4lq1A:21.78;1v55C-4lq1A:18.69"],["2DYR_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","2dyrA-4lq1A:undetectable;2dyrC-4lq1A:undetectable","2dyrA-4lq1A:21.78;2dyrC-4lq1A:18.69"],["2DYR_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.46A","2dyrN-4lq1A:2.0;2dyrP-4lq1A:undetectable","2dyrN-4lq1A:21.78;2dyrP-4lq1A:18.69"],["2DYS_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.48A","2dysA-4lq1A:undetectable;2dysC-4lq1A:undetectable","2dysA-4lq1A:21.78;2dysC-4lq1A:18.69"],["2DYS_P_CHDP304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.45A","2dysN-4lq1A:undetectable;2dysP-4lq1A:undetectable","2dysN-4lq1A:21.78;2dysP-4lq1A:18.69"],["2EIJ_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.44A","2eijA-4lq1A:undetectable;2eijC-4lq1A:undetectable","2eijA-4lq1A:21.78;2eijC-4lq1A:18.69"],["2EIJ_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.46A","2eijN-4lq1A:2.1;2eijP-4lq1A:undetectable","2eijN-4lq1A:21.78;2eijP-4lq1A:18.69"],["2EIK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","2eikA-4lq1A:2.0;2eikC-4lq1A:undetectable","2eikA-4lq1A:21.78;2eikC-4lq1A:18.69"],["2EIK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","2eikN-4lq1A:2.1;2eikP-4lq1A:undetectable","2eikN-4lq1A:21.78;2eikP-4lq1A:18.69"],["2EIL_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","2eilN-4lq1A:undetectable;2eilP-4lq1A:undetectable","2eilN-4lq1A:21.78;2eilP-4lq1A:18.69"],["2EIM_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.43A","2eimA-4lq1A:undetectable;2eimC-4lq1A:undetectable","2eimA-4lq1A:21.78;2eimC-4lq1A:18.69"],["2EIN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.45A","2einA-4lq1A:undetectable;2einC-4lq1A:undetectable","2einA-4lq1A:21.78;2einC-4lq1A:18.69"],["2EIN_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.46A","2einN-4lq1A:undetectable;2einP-4lq1A:undetectable","2einN-4lq1A:21.78;2einP-4lq1A:18.69"],["2HMY_B_SAMB328_0","PROTEIN (CYTOSINE-SPECIFIC METHYLTRANSFERASE HHAI)","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 318;GLY A 251;ASP A 323;ILE A 322;PRO A 308","None","1.05A","2hmyB-4lq1A:undetectable","2hmyB-4lq1A:19.71"],["2OWC_A_ACRA600_1","4-ALPHA-GLUCANOTRANSFERASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",6,"TYR A 300;GLN A 301;ASP A 405;HIS A 525;ASP A 526;TRP A 298","None","1.16A","2owcA-4lq1A:15.2","2owcA-4lq1A:22.24"],["2OWW_A_ACRA600_1","4-ALPHA-GLUCANOTRANSFERASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",6,"TYR A 300;GLN A 301;ASP A 405;HIS A 525;ASP A 526;TRP A 298","None","1.15A","2owwA-4lq1A:15.2","2owwA-4lq1A:22.24"],["2QMZ_B_LDPB502_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE;RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"PHE A 560;PHE A 641;TRP A 628;GLY A 625","None","1.35A","2qmzA-4lq1A:undetectable;2qmzB-4lq1A:undetectable","2qmzA-4lq1A:18.49;2qmzB-4lq1A:18.49"],["2TSR_C_D16C509_1","THYMIDYLATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.36A","2tsrC-4lq1A:undetectable","2tsrC-4lq1A:17.78"],["2TSR_D_D16D609_1","THYMIDYLATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.41A","2tsrD-4lq1A:undetectable","2tsrD-4lq1A:17.78"],["2VL2_B_BEZB1162_0","PEROXIREDOXIN-5","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"PRO A 338;GLY A 339;LEU A 475;PHE A 477","None","0.96A","2vl2B-4lq1A:undetectable","2vl2B-4lq1A:14.90"],["2Y69_A_CHDA1517_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.44A","2y69A-4lq1A:2.0;2y69C-4lq1A:undetectable","2y69A-4lq1A:21.78;2y69C-4lq1A:18.69"],["2ZXW_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.48A","2zxwA-4lq1A:undetectable;2zxwC-4lq1A:undetectable","2zxwA-4lq1A:21.78;2zxwC-4lq1A:18.69"],["2ZXW_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.48A","2zxwN-4lq1A:undetectable;2zxwP-4lq1A:undetectable","2zxwN-4lq1A:21.78;2zxwP-4lq1A:18.69"],["3ABK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.48A","3abkA-4lq1A:undetectable;3abkC-4lq1A:undetectable","3abkA-4lq1A:21.78;3abkC-4lq1A:18.69"],["3ABK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","3abkN-4lq1A:undetectable;3abkP-4lq1A:undetectable","3abkN-4lq1A:21.78;3abkP-4lq1A:18.69"],["3ABM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.48A","3abmN-4lq1A:undetectable;3abmP-4lq1A:undetectable","3abmN-4lq1A:21.78;3abmP-4lq1A:18.69"],["3AG1_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.49A","3ag1N-4lq1A:undetectable;3ag1P-4lq1A:undetectable","3ag1N-4lq1A:21.78;3ag1P-4lq1A:18.69"],["3AG2_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.46A","3ag2A-4lq1A:undetectable;3ag2C-4lq1A:undetectable","3ag2A-4lq1A:21.78;3ag2C-4lq1A:18.69"],["3AG2_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.46A","3ag2N-4lq1A:undetectable;3ag2P-4lq1A:undetectable","3ag2N-4lq1A:21.78;3ag2P-4lq1A:18.69"],["3AG3_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","3ag3A-4lq1A:undetectable;3ag3C-4lq1A:undetectable","3ag3A-4lq1A:21.78;3ag3C-4lq1A:18.69"],["3AG3_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.48A","3ag3N-4lq1A:undetectable;3ag3P-4lq1A:undetectable","3ag3N-4lq1A:21.78;3ag3P-4lq1A:18.69"],["3AG4_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.46A","3ag4A-4lq1A:undetectable;3ag4C-4lq1A:undetectable","3ag4A-4lq1A:21.78;3ag4C-4lq1A:18.69"],["3AG4_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.44A","3ag4N-4lq1A:undetectable;3ag4P-4lq1A:undetectable","3ag4N-4lq1A:21.78;3ag4P-4lq1A:18.69"],["3AIC_A_ACRA5044_1","GLUCOSYLTRANSFERASE-SI","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"ARG A 403;ASP A 405;ALA A 406;HIS A 525;ASP A 526","None","0.86A","3aicA-4lq1A:2.5","3aicA-4lq1A:21.03"],["3AIC_B_ACRB5044_1","GLUCOSYLTRANSFERASE-SI","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"ARG A 403;ASP A 405;ALA A 406;HIS A 525;ASP A 526","None","0.88A","3aicB-4lq1A:4.7","3aicB-4lq1A:21.03"],["3AIC_C_ACRC5044_1","GLUCOSYLTRANSFERASE-SI","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",6,"ARG A 403;ASP A 405;ALA A 406;HIS A 525;ASP A 526;TYR A 300","None","0.90A","3aicC-4lq1A:5.7","3aicC-4lq1A:21.03"],["3AIC_D_ACRD5044_1","GLUCOSYLTRANSFERASE-SI","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"ARG A 403;ASP A 405;ALA A 406;HIS A 525;ASP A 526","None","0.90A","3aicD-4lq1A:5.3","3aicD-4lq1A:21.03"],["3AIC_E_ACRE5044_1","GLUCOSYLTRANSFERASE-SI","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"ARG A 403;ASP A 405;ALA A 406;HIS A 525;ASP A 526","None","0.86A","3aicE-4lq1A:5.6","3aicE-4lq1A:21.03"],["3AIC_F_ACRF5044_1","GLUCOSYLTRANSFERASE-SI","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"ARG A 403;ASP A 405;ALA A 406;HIS A 525;ASP A 526","None","0.86A","3aicF-4lq1A:4.1","3aicF-4lq1A:21.03"],["3AIC_G_ACRG5044_1","GLUCOSYLTRANSFERASE-SI","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"ARG A 403;ASP A 405;ALA A 406;HIS A 525;ASP A 526","None","0.87A","3aicG-4lq1A:5.6","3aicG-4lq1A:21.03"],["3AIC_H_ACRH5044_1","GLUCOSYLTRANSFERASE-SI","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"ARG A 403;ASP A 405;ALA A 406;HIS A 525;ASP A 526","None","0.87A","3aicH-4lq1A:4.6","3aicH-4lq1A:21.03"],["3ASN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.46A","3asnA-4lq1A:undetectable;3asnC-4lq1A:undetectable","3asnA-4lq1A:21.78;3asnC-4lq1A:18.69"],["3JAY_A_SAMA1102_1","STRUCTURAL PROTEIN VP3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",3,"ARG A 315;ASP A 323;ASP A 316","None","0.76A","3jayA-4lq1A:undetectable","3jayA-4lq1A:18.40"],["3JB2_A_SAMA1102_1","STRUCTURAL PROTEIN VP3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",3,"ARG A 315;ASP A 323;ASP A 316","None","0.86A","3jb2A-4lq1A:undetectable","3jb2A-4lq1A:18.40"],["3JB3_A_SAMA1102_1","STRUCTURAL PROTEIN VP3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",3,"ARG A 315;ASP A 323;ASP A 316","None","0.91A","3jb3A-4lq1A:undetectable","3jb3A-4lq1A:18.40"],["3P2K_B_SAMB6735_0","16S RRNA METHYLASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PRO A 338;ALA A 390;LEU A 286;THR A 455;LEU A 402","None","1.14A","3p2kB-4lq1A:undetectable","3p2kB-4lq1A:17.93"],["3PYY_A_STIA3_2","V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"TYR A 375;VAL A 404;ILE A 411;ARG A 444","None","0.92A","3pyyA-4lq1A:undetectable","3pyyA-4lq1A:20.26"],["3TYE_B_YTZB902_1","DIHYDROPTEROATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",3,"PHE A 346;LYS A 202;SER A 203","None","1.33A","3tyeB-4lq1A:5.0","3tyeB-4lq1A:18.49"],["4AC9_C_DXCC1480_0","MJ0495-LIKE PROTEIN","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"LYS A 563;GLU A 285;ILE A 245;SER A 244","None","1.46A","4ac9C-4lq1A:2.7","4ac9C-4lq1A:21.71"],["4ACA_C_DXCC1480_0","TRANSLATION ELONGATION FACTOR SELB","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"LYS A 563;GLU A 285;ILE A 245;SER A 244","None","1.41A","4acaC-4lq1A:2.8","4acaC-4lq1A:21.71"],["4ACB_C_DXCC1480_0","TRANSLATION ELONGATION FACTOR SELB","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"LYS A 563;GLU A 285;ILE A 245;SER A 244","None","1.42A","4acbC-4lq1A:2.8","4acbC-4lq1A:21.71"],["4AE1_B_NCAB1536_0","DIPHTHERIA TOXIN","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"HIS A 128;GLY A 126;TYR A 122;TYR A 206","None","1.08A","4ae1B-4lq1A:3.2","4ae1B-4lq1A:21.43"],["4DO3_B_0LAB602_1","FATTY-ACID AMIDE HYDROLASE 1","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"LEU A 119;LEU A 391;ILE A 394;TRP A 336","None","0.87A","4do3B-4lq1A:undetectable","4do3B-4lq1A:21.67"],["4EB4_C_D16C402_1","THYMIDYLATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.38A","4eb4C-4lq1A:undetectable","4eb4C-4lq1A:17.78"],["4EB4_D_D16D402_1","THYMIDYLATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.36A","4eb4D-4lq1A:undetectable","4eb4D-4lq1A:17.78"],["4O4D_A_ACTA406_0","INOSITOL HEXAKISPHOSPHATE KINASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"THR A 303;PHE A 294;SER A 297;HIS A 292","None","1.39A","4o4dA-4lq1A:undetectable","4o4dA-4lq1A:16.67"],["4R82_A_ACTA205_0","OXIDOREDUCTASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"SER A 172;GLY A 173;ARG A 169;GLU A 176","None","1.29A","4r82A-4lq1A:undetectable;4r82B-4lq1A:undetectable","4r82A-4lq1A:16.33;4r82B-4lq1A:16.33"],["4WS0_A_URFA301_1","URACIL-DNA GLYCOSYLASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"GLY A 126;TYR A 392;PHE A 208;HIS A 128","None","1.14A","4ws0A-4lq1A:undetectable","4ws0A-4lq1A:15.36"],["5B1A_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.48A","5b1aN-4lq1A:undetectable;5b1aP-4lq1A:undetectable","5b1aN-4lq1A:21.78;5b1aP-4lq1A:18.69"],["5B1B_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","5b1bN-4lq1A:undetectable;5b1bP-4lq1A:undetectable","5b1bN-4lq1A:21.78;5b1bP-4lq1A:18.69"],["5B3S_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","5b3sN-4lq1A:undetectable;5b3sP-4lq1A:undetectable","5b3sN-4lq1A:21.78;5b3sP-4lq1A:18.69"],["5H3A_A_D16A401_1","ORF70","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.35A","5h3aA-4lq1A:undetectable","5h3aA-4lq1A:20.13"],["5IY5_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","5iy5A-4lq1A:undetectable;5iy5C-4lq1A:undetectable","5iy5A-4lq1A:21.78;5iy5C-4lq1A:18.89"],["5N0S_B_SAMB501_1","PEPTIDE N-METHYLTRANSFERASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"GLY A 197;ALA A 195;MET A 192;THR A 354","None","1.38A","5n0sB-4lq1A:undetectable","5n0sB-4lq1A:19.60"],["5X1B_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.47A","5x1bN-4lq1A:undetectable;5x1bP-4lq1A:undetectable","5x1bN-4lq1A:21.78;5x1bP-4lq1A:18.69"],["5X5Q_C_D16C402_1","THYMIDYLATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.34A","5x5qC-4lq1A:undetectable","5x5qC-4lq1A:17.55"],["5X66_D_MTXD402_1","THYMIDYLATE SYNTHASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"PHE A 560;ILE A 511;ASP A 622;GLY A 625;PHE A 626","None","1.33A","5x66D-4lq1A:undetectable","5x66D-4lq1A:17.55"],["5ZCQ_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"ASP A 491;THR A 489;TYR A 492;TRP A 628","None","1.46A","5zcqN-4lq1A:undetectable;5zcqP-4lq1A:undetectable","5zcqN-4lq1A:21.78;5zcqP-4lq1A:18.69"],["6DWN_B_AQ4B602_0","CYTOCHROME P450 1A1","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"ILE A 289;ASN A 389;LEU A 305;ASN A 290;ILE A 322","None","1.29A","6dwnB-4lq1A:undetectable","6dwnB-4lq1A:8.72"],["6FZB_B_SRYB301_1","STREPTOMYCIN 3''-ADENYLYLTRANSFERASE","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",5,"ASP A 345;ASP A 295;ASP A 335;ILE A 289;THR A 309","None","1.44A","6fzbB-4lq1A:undetectable","6fzbB-4lq1A:8.94"],["6MN4_F_AM2F301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","4lq1","1,4-ALPHA-GLUCAN BRANCHING ENZYME GLGB","Escherichia coli",4,"HIS A 487;HIS A 530;GLU A 527;GLU A 247","None","1.31A","6mn4F-4lq1A:undetectable","6mn4F-4lq1A:17.46"]]